Neurogene (NGNE) Capital Leases (2015 - 2026)
Neurogene's Capital Leases was $3,000 in Q2 2026, down 66.7% from $9,000 a year earlier and down 25.0% from the prior quarter.
Powered by 
Analysis
Neurogene (NGNE) Capital Leases (2015 - 2026) Analysis & Trends
At the end of FY2025, Capital Leases at Neurogene came in at $5,000, down 80.8% from FY2024.
- Capital Leases has now declined for six consecutive years, with a five-year compound annual growth rate of -45.9% (FY2020 to FY2025).
- In earlier years, Capital Leases was $26,000 in FY2024 (-60.0%), $65,000 in FY2023 (-1.5%), $66,000 in FY2022 (-1.5%) and $67,000 in FY2021 (-38.0%).
- The Q2 2026 figure marks the lowest quarterly Capital Leases in data going back to Q4 2015.
- Compared with a year earlier, Capital Leases has declined for seven straight quarters, with growth averaging 20.4% over the last eight quarters.
- The best year-over-year quarter for Capital Leases over five years was Q2 2024 (growth of 783.3%); the worst was Q1 2023 (a decline of 89.4%).
- Per Business Quant data, NGNE's Capital Leases in the three quarters before Q2 2026 was $4,000 (Q1 2026), $5,000 (Q4 2025) and $7,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Neurogene | 586.35 Mn | -416.64 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3,000.00 |
| Mar 31, 2026 | 4,000.00 |
| Dec 31, 2025 | 5,000.00 |
| Sep 30, 2025 | 7,000.00 |
| Jun 30, 2025 | 9,000.00 |
| Mar 31, 2025 | 17,000.00 |
| Dec 31, 2024 | 26,000.00 |
| Sep 30, 2024 | 39,000.00 |
| Jun 30, 2024 | 53,000.00 |
| Mar 31, 2024 | 53,000.00 |
| Dec 31, 2023 | 65,000.00 |
| Sep 30, 2023 | 5,000.00 |
| Jun 30, 2023 | 6,000.00 |
| Mar 31, 2023 | 7,000.00 |
| Dec 31, 2022 | 66,000.00 |
| Sep 30, 2022 | 9,000.00 |
| Jun 30, 2022 | 10,000.00 |
| Mar 31, 2022 | 66,000.00 |
| Dec 31, 2021 | 67,000.00 |
| Sep 30, 2021 | 68,000.00 |
API Access
Neurogene Capital Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-leases&ticker=NGNE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-leases", "ticker": "NGNE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-leases&ticker=NGNE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();